MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Spasticity: Treatment"

  • 2025 International Congress

    Extracorporeal Shockwave Therapy (ESWT) for Neck Pain and Shoulder-Scapular Dyskinesis: An Objective Evaluation Study

    L. Kalika, R. Bubnov (Kyiv, Ukraine)

    Objective: The aim was to objectively evaluate the role of shoulder and scapular movement in neck pain and assess the efficacy of ESWT for treatment.…
  • 2025 International Congress

    Continuous subcutaneous foslevodopa/foscarbidopa infusion therapy leads to a sustained reduction in dyskinesias in Parkinson’s disease

    M. Georgiades, D. Tsui, X. Chen, S. Bray, J. Qiu, S. Waller, L. Williams, S. Dal, T. Ong, A. Martin, H. Morales-Briceno, V. Fung (Sydney, Australia)

    Objective: To assess the longitudinal effect of continuous subcutaneous foslevodopa/foscarbidopa infusion therapy on dyskinesias as measured by the Unified Dyskinesia Rating Scale (UDysRS) total score…
  • 2025 International Congress

    Characteristics of IncobotulinumtoxinA Treatment for Limb Spasticity in a Real-World Setting: Dosing and Muscles Injected

    J. Holmes, A. Kong, G. Askin, D. Nomah, D. Joseph, K. Biney, M. Hast (Raleigh, USA)

    Objective: This study described incobotulinumtoxinA doses and muscles injected in a real-world setting for patients with limb spasticity (LS). Background: IncobotulinumtoxinA is approved to treat…
  • 2024 International Congress

    Feasibility and Comprehensibility of the SMD Decision Tree for Early Recognition of Spasticity

    K. Fheodoroff, B. Waeschle, J. Wissel (Hermagor, Austria)

    Objective: The comprehensibility, feasibility, and appraisal of the Spastic Movement Disorders Decision Tree (SMD-DT) was assessed by qualitative analysis of study feedback collected from raters…
  • 2024 International Congress

    Pathways for diagnosis and multimodal management, including botulinum neurotoxin therapy, in shoulder conditions following central lesions

    B. Biering-Sørensen, C. Cordero-García, C. Boulias, D. Hoad, D. Bensmail, F. Molteni, F. Genêt, J. Wissel, P. Marque, S. Berweck, J. Jacinto (Glostrup, Denmark)

    Objective: To build on existing publications and give guidance for healthcare providers managing shoulder conditions following central lesions, including how to identify, diagnose, and treat…
  • 2024 International Congress

    Social Media Listening Study to Understand the Journey and Unmet Needs of Patients Living With PSS

    S. Carda, J. Wissel, D. Hoad, G. Francisco, M. Verduzco-Gutierrez, D. Gallardo, M. Vacchelli, J. Jacinto (Lausanne, Switzerland)

    Objective: To employ social media listening to uncover insights into poststroke spasticity (PSS) patient experiences, unmet needs, and impact on quality of life. Background: PSS…
  • 2024 International Congress

    Impact of Patient Input on the Study Execution of a Prospective, Epidemiological Study

    R. Zorowitz, L. Barrenechea, S. Butet, S. Groppa, D. Herrero, R. Prasad, S. Sandars, P. Maisonobe, S. Page, A. Picelli (Washington, USA)

    Objective: To demonstrate the direct impact patient input had on the study design and execution of the Epitome study (NCT06055725). Background: It is increasingly accepted…
  • 2024 International Congress

    Goal Attainment and Ambulation With Increasing Doses of IncobotulinumtoxinA: A Post Hoc Analysis of the TOWER Study

    D. Bensmail, K. Fheodoroff, A. Hanschmann, L. Nicolson, W. Clarke, M. Vacchelli, J. Wissel (Garches, France)

    Objective: To evaluate goal attainment and ambulation in a subpopulation of TOWER study patients treated with UK licensed doses of incobotulinumtoxinA (incoA) for injection cycles…
  • 2024 International Congress

    Moderate-to-severe upper limb spasticity patterns in the elderly are improved following treatment with incobotulinumtoxinA: a pooled analysis

    M. Munin, A. Camões-Barbosa, C. Cordero-García, M. Althaus, G. Comes, M. Vacchelli, C. Walter, J. Wissel (Pittsburgh, USA)

    Objective: To compare upper limb spasticity (ULS) severity changes from baseline in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA (incoA)…
  • 2024 International Congress

    Improvement in upper limb spasticity patterns in the elderly following treatment with incobotulinumtoxinA: a pooled analysis

    M. Munin, A. Camões-Barbosa, C. Cordero-García, M. Althaus, G. Comes, M. Vacchelli, C. Walter, J. Wissel (Pittsburgh, USA)

    Objective: To compare changes from baseline in upper limb spasticity (ULS) severity in different spastic patterns at 4 weeks and 12 weeks post-injection of incobotulinumtoxinA…
  • 1
  • 2
  • 3
  • …
  • 7
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley